End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.23 CNY | +3.00% | +10.62% | -22.80% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The firm trades with high earnings multiples: 31.06 times its 2023 earnings per share.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.80% | 309M | - | ||
-9.06% | 17.38B | A- | ||
-9.81% | 3.89B | C+ | ||
+3.08% | 3.6B | B- | ||
-3.52% | 2.44B | - | C- | |
-13.60% | 1.56B | C- | ||
+40.30% | 1.26B | - | ||
+13.83% | 928M | - | ||
+24.39% | 820M | B | ||
+25.47% | 436M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 301009 Stock
- Ratings Hangzhou Coco Healthcare Products Co.,Ltd.